• Skip to main content
Scientific Sessions
Scientific Sessions Conference Coverage logo
  • Program
  • #AHA25
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Resources
  • Program
  • #AHA25
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Resources
  • Program
  • #AHA25
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 18th, 2024

Streamlining the pathway to publish cardiovascular research

Starting in 2025, research authors will have the option to select a seamless transfer of their manuscript between NEJM and Circulation.


Aha24 Nejm Web Image

The American Heart Association (AHA) is thrilled to announce a new collaboration between the New England Journal of Medicine (NEJM) and the AHA’s flagship journal Circulation. In January 2025, research authors will have the option to select a seamless transfer of their manuscript between NEJM and Circulation.

This pilot program leverages the expertise of the journals’ world-class editors and peer reviewers to streamline the publication of novel cardiovascular research.

NEJM is the most widely read and cited general medicine journal in the world, and coupled with Circulation’s stature in cardiology this arrangement helps to expedite the submission process for authors, simplifying the publication pathway for high-impact cardiovascular articles. This collaboration aims to strengthen, diversify and improve the quality of research published in both journals, providing greater benefits to authors and readers.

Together, the journals are set to amplify the sharing of innovative cardiovascular research, speed the publication of practice-changing science and address pressing health challenges, while underscoring each organization’s commitment to improving global health outcomes for the benefit of patients everywhere.

Interesting Stories
Unmet Needs in Hypertension Toolkit
Sponsored by Medtronic
Unmet Needs in Hypertension Toolkit
Join our presentation about severe hypertriglyceridemia (sHTG)
Sponsored by Ionis Pharmaceuticals
Join our presentation about severe hypertriglyceridemia (sHTG)
Recurrent Pericarditis Toolkit
Sponsored by Kiniksa Pharmaceuticals
Recurrent Pericarditis Toolkit
More Content
241116 American Heart Association Keynote 0080
AHA24
Advances in lipid therapeutics
Nov 20th, 2024
Crowd shot
AHA24
New approaches to managing AFib
Nov 20th, 2024
Stage shot
AHA24
Medical therapy for heart failure
Nov 20th, 2024
Stage shot
AHA24
Innovation in prevention
Nov 20th, 2024
French Quarter balcony shot
AHA24
Save the date for #AHA25 in New Orleans
Nov 20th, 2024
Asgar headshot
AHA24
Managing patients with symptomatic mitral or tricuspid regurgitation
Nov 18th, 2024
Shot of speakers
AHA24
Environmental crises call for more CV research
Nov 18th, 2024
Casadei headshot
AHA24
Dissecting the complex relationship between atrial cardiomyopathy and stroke
Nov 18th, 2024
Stage shot
AHA24
Coronary and valvular heart disease
Nov 18th, 2024
Headshots of speakers
AHA24
Improving patient outcomes for sudden cardiac arrest
Nov 18th, 2024
audience shot
AHA24
Redefining arrhythmia treatment
Nov 18th, 2024
Headshots of speakers
AHA24
At the intersection of heart and brain
Nov 17th, 2024